WebJul 28, 2024 · B iotech giant Pfizer expects to generate $33.5 billion in Covid-19 vaccine sales in 2024, up from previous estimates of $26 billion, according to its second quarter earnings reports. These... WebMar 10, 2024 · The federal government has so far purchased 1.2 billion doses of Pfizer and Moderna COVID-19 vaccines combined, at a cost of $25.3 billion, or a weighted average purchase price of $20.69 per dose.
How Much Could COVID-19 Vaccines Cost the U.S. After …
WebMar 31, 2024 · “Pfizer has spent at risk, almost $2 billion on the overall program. From manufacturing, my team spent $500 million, before we even got out of clinical trials. So all completely at risk. We... WebMar 3, 2024 · Pfizer sold $36.7 billion of its Covid vaccine worldwide in 2024, representing 45% of its total year revenue of $81.2 billion. Moderna’s vaccine is its only commercially available product, and... high c reactive protein treatment
Pfizer Brought in $3.5 Billion From COVID-19 Shots in Q1 - Business Insider
WebDec 11, 2024 · Pfizer (PFE) by itself is projected to haul in $19 billion in Covid-19 vaccine revenue in 2024, according to Morgan Stanley. That’s on top of an estimated $975 million in 2024 vaccine revenue.... WebJul 28, 2024 · J&J last week estimated full-year COVID-19 vaccine sales of $US 2.5 billion ($3.4 billion), while Moderna has forecasted $US 19.2 billion ($26.1 billion). Pfizer said it has shipped 1 billion doses of the vaccine since December. The company has a production target of around 3 billion doses this year. WebSep 15, 2024 · Pfizer has sold more than $11 billion in vaccines in the first half of this year. Pfizer is now projecting $33.5 billion in total vaccine sales for 2024, making the vaccine one of the top selling pharma products this year and potentially in the history of the pharmaceutical industry. high creatinine and hbp medication